Alerts will be sent to your verified email
Verify Email
RPGLIFE
|
RPG Life Sciences
|
Guj. Themis Biosyn
|
Advanced Enzyme
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Domestic Sales Growth - YoY
|
-11.18 % | n/a | n/a |
|
R&D as a % of Total Sales
|
1.5 % | n/a | 7.5 % |
|
Financials
|
|||
|
5 yr Average ROE
|
20.08 % | 41.95 % | 12.01 % |
|
5yr average Equity Multiplier
|
1.4 | 1.37 | 1.16 |
|
5yr Average Asset Turnover Ratio
|
1.26 | 0.89 | 0.42 |
|
5yr Avg Net Profit Margin
|
11.59 % | 34.6 % | 24.34 % |
|
Price to Book
|
7.36 | 14.79 | 2.7 |
|
P/E
|
21.31 | 75.3 | 29.25 |
|
5yr Avg Cash Conversion Cycle
|
-64.92 Days | -31.8 Days | 87.24 Days |
|
Inventory Days
|
63.34 Days | 23.52 Days | 72.86 Days |
|
Days Receivable
|
25.32 Days | 48.29 Days | 58.11 Days |
|
Days Payable
|
145.09 Days | 135.34 Days | 50.65 Days |
|
5yr Average Interest Coverage Ratio
|
17.66 | 187.52 | 54.91 |
|
5yr Avg ROCE
|
27.52 % | 54.74 % | 16.0 % |
|
5yr Avg Operating Profit Margin
|
19.26 % | 45.69 % | 38.48 % |
|
5 yr average Debt to Equity
|
0.02 | 0.05 | 0.02 |
|
5yr CAGR Net Profit
|
24.75 % | 20.11 % | 0.61 % |
|
5yr Average Return on Assets
|
14.44 % | 30.29 % | 10.35 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.95 % | 70.86 % | 43.08 % |
|
Share Pledged by Promoters
|
0.0 | 3.3 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.88 % | -4.13 % | -9.62 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
3.53 % | 1.14 % | -1.1 % |
|
RPG Life Sciences
|
Guj. Themis Biosyn
|
Advanced Enzyme
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|